Clinical Trial Update: Different Doses of Colchicine on hsCRP [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating different doses of colchicine on hsCRP in patients with coronary artery disease undergoing percutaneous coronary intervention has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Percutaneous Coronary Intervention

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Coronary Artery Disease, Percutaneous Coronary Intervention | Phase 4 | Status: COMPLETED